{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:51:15Z","timestamp":1785423075843,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10620-025-09240-3","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T12:53:39Z","timestamp":1753448019000},"page":"3453-3464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gastrointestinal Manifestations of Yao Syndrome (NOD2-Associated Autoinflammatory Disease)"],"prefix":"10.1007","volume":"70","author":[{"given":"John A.","family":"Damianos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash K.","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"9240_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/ar3462","volume":"13","author":"Q Yao","year":"2011","unstructured":"Yao Q, Zhou L, Cusumano P et al. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Research & Therapy. 2011;13:148.","journal-title":"Arthritis Research & Therapy."},{"key":"9240_CR2","doi-asserted-by":"publisher","first-page":"365.e313","DOI":"10.1016\/j.amjmed.2016.09.028","volume":"130","author":"Q Yao","year":"2017","unstructured":"Yao Q, Shen B. A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease. The American Journal of Medicine. 2017;130:365.e313-365.e318.","journal-title":"The American Journal of Medicine."},{"key":"9240_CR3","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s10067-018-4274-0","volume":"37","author":"X Yang","year":"2018","unstructured":"Yang X, Wu D, Li J, Shen M, Zhang W. A Chinese case series of Yao syndrome and literature review. Clinical Rheumatology. 2018;37:3449\u20133454.","journal-title":"Clinical Rheumatology."},{"key":"9240_CR4","doi-asserted-by":"publisher","first-page":"1304792","DOI":"10.3389\/fimmu.2024.1304792","volume":"15","author":"KA Williamson","year":"2024","unstructured":"Williamson KA, Samec MJ, Patel JA et al. Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series. Front Immunol. 2024;15:1304792.","journal-title":"Front Immunol."},{"key":"9240_CR5","doi-asserted-by":"publisher","first-page":"1458118","DOI":"10.3389\/fimmu.2024.1458118","volume":"15","author":"H Nomani","year":"2024","unstructured":"Nomani H, Wu S, Saif A et al. Comprehensive clinical phenotype, genotype and therapy in Yao syndrome. Front Immunol. 2024;15:1458118.","journal-title":"Front Immunol."},{"key":"9240_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/rheumatology\/kead372","volume":"63","author":"KA Williamson","year":"2023","unstructured":"Williamson KA, Yun M, Koster MJ et al. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple\u2019s disease. Rheumatology. 2023;63:1291\u20131296.","journal-title":"Rheumatology."},{"key":"9240_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/00365520310004209","volume":"38","author":"IK Wiklund","year":"2003","unstructured":"Wiklund IK, Fullerton S, Hawkey CJ et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2003;38:947\u2013954.","journal-title":"Scand J Gastroenterol."},{"key":"9240_CR8","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/ajg.2012.221","volume":"107","author":"J Noelting","year":"2012","unstructured":"Noelting J, Ratuapli SK, Bharucha AE, Harvey DM, Ravi K, Zinsmeister AR. Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol. 2012;107:1530\u20131536.","journal-title":"Am J Gastroenterol."},{"key":"9240_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13510","volume":"31","author":"V Chedid","year":"2019","unstructured":"Chedid V, Vijayvargiya P, Halawi H, Park S-Y, Camilleri M. Audit of the diagnosis of rectal evacuation disorders in chronic constipation. Neurogastroenterology & Motility. 2019;31:e13510.","journal-title":"Neurogastroenterology & Motility."},{"key":"9240_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11894-020-00793-z","volume":"22","author":"SM Scott","year":"2020","unstructured":"Scott SM, Carrington EV. The London classification: Improving characterization and classification of anorectal function with anorectal manometry. Curr Gastroenterol Rep. 2020;22:55.","journal-title":"Curr Gastroenterol Rep."},{"key":"9240_CR11","first-page":"e156","volume":"28","author":"Q Yao","year":"2022","unstructured":"Yao Q, Kontzias A. Expansion of phenotypic and genotypic spectrum in Yao syndrome: A case series. JCR: Journal of Clinical Rheumatology. 2022;28:e156\u2013e160.","journal-title":"JCR: Journal of Clinical Rheumatology."},{"key":"9240_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ijd.17350","volume":"64","author":"M Shakhashiro","year":"2025","unstructured":"Shakhashiro M, Sadeghian S, Newcomer J et al. Yao syndrome: A novel systemic autoinflammatory disease with cutaneous manifestations. International Journal of Dermatology. 2025;64:44.","journal-title":"International Journal of Dermatology."},{"key":"9240_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000540188","volume":"186","author":"A Khalid","year":"2024","unstructured":"Khalid A, Kaell A. Yao syndrome: An overview of genotypic associations, clinical manifestations, diagnosis, and treatment. International Archives of Allergy and Immunology. 2024;186:1\u201313.","journal-title":"International Archives of Allergy and Immunology."},{"key":"9240_CR14","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/rheumatology\/kev207","volume":"54","author":"Q Yao","year":"2015","unstructured":"Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2-associated autoinflammatory disease: A large cohort study. Rheumatology. 2015;54:1904\u20131912.","journal-title":"Rheumatology."},{"key":"9240_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/PAS.0b013e318196a67f","volume":"33","author":"ST Leung","year":"2009","unstructured":"Leung ST, Chandan VS, Murray JA, Wu TT. Collagenous gastritis: Histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol. 2009;33:788\u2013798.","journal-title":"Am J Surg Pathol."},{"key":"9240_CR16","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1007\/s10620-021-07232-7","volume":"67","author":"M Aziz","year":"2022","unstructured":"Aziz M, Haghbin H, Khan RS et al. Celiac disease is associated with microscopic colitis in refractory cases in adults: A systematic review and meta-analysis of observational studies. Digestive Diseases and Sciences. 2022;67:3529\u20133542.","journal-title":"Digestive Diseases and Sciences."},{"key":"9240_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.14309\/ajg.0000000000001834","volume":"117","author":"K M\u00e5rild","year":"2022","unstructured":"M\u00e5rild K, S\u00f6derling J, Lebwohl B et al. Association of celiac disease and inflammatory bowel disease: A nationwide register-based cohort study. Am J Gastroenterol. 2022;117:1471\u20131481.","journal-title":"Am J Gastroenterol."},{"key":"9240_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","volume":"43","author":"Q Yao","year":"2013","unstructured":"Yao Q. Nucleotide-binding oligomerization domain containing 2: Structure, function, and diseases. Seminars in Arthritis and Rheumatism. 2013;43:125\u2013130.","journal-title":"Seminars in Arthritis and Rheumatism."},{"key":"9240_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08916934.2018.1442442","volume":"51","author":"C McDonald","year":"2018","unstructured":"McDonald C, Shen M, Johnson EE, Kabi A, Yao Q. Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome. Autoimmunity. 2018;51:53\u201361.","journal-title":"Autoimmunity."},{"key":"9240_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/ecco-jcc\/jjac124","volume":"17","author":"JJ Ashton","year":"2022","unstructured":"Ashton JJ, Seaby EG, Beattie RM, Ennis S. NOD2 in Crohn\u2019s disease\u2014Unfinished business. Journal of Crohn\u2019s and Colitis. 2022;17:450\u2013458.","journal-title":"Journal of Crohn\u2019s and Colitis."},{"key":"9240_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.gtc.2017.05.004","volume":"46","author":"S Khanna","year":"2017","unstructured":"Khanna S, Raffals LE. The microbiome in Crohn\u2019s disease: role in pathogenesis and role of microbiome replacement therapies. Gastroenterology Clinics. 2017;46:481\u2013492.","journal-title":"Gastroenterology Clinics."},{"key":"9240_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/apt.15133","volume":"49","author":"A Shah","year":"2019","unstructured":"Shah A, Morrison M, Burger D et al. Systematic review with meta-analysis: The prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2019;49:624\u2013635.","journal-title":"Alimentary Pharmacology & Therapeutics."},{"key":"9240_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cgh.2024.07.020","volume":"23","author":"S Mehravar","year":"2024","unstructured":"Mehravar S, Takakura W, Wang J, Pimentel M, Nasser J, Rezaie A. Symptom profile of patients with intestinal methanogen overgrowth: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2024;23:1111.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9240_CR24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.cgh.2024.04.009","volume":"22","author":"S Dilmaghani","year":"2024","unstructured":"Dilmaghani S, Lupianez-Merly C, Fetzer J, BouSaba J, Halawi H, Camilleri M. Colon volume by computed tomography and scintigraphic colonic transit in constipated patients with or without redundant colon. Clinical Gastroenterology and Hepatology. 2024;22:2327.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9240_CR25","doi-asserted-by":"publisher","first-page":"S1656","DOI":"10.14309\/01.ajg.0000714660.32906.3b","volume":"115","author":"W Takakura","year":"2020","unstructured":"Takakura W, Raphael Y, Sukov R, Rezaie A. S3153 hypermobile Ehlers-Danlos syndrome and visceroptosis. Official Journal of the American College of Gastroenterology ACG. 2020;115:S1656\u2013S1657.","journal-title":"Official Journal of the American College of Gastroenterology ACG."},{"key":"9240_CR26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ajg.2012.260","volume":"107","author":"SJ Halpin","year":"2012","unstructured":"Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. Official Journal of the American College of Gastroenterology ACG. 2012;107:1474\u20131482.","journal-title":"Official Journal of the American College of Gastroenterology ACG."},{"key":"9240_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cgh.2012.11.033","volume":"11","author":"A Sainsbury","year":"2013","unstructured":"Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome\u2013type symptoms in patients with celiac disease: a meta-analysis. Clinical Gastroenterology and Hepatology. 2013;11:359-365.e351.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9240_CR28","doi-asserted-by":"publisher","first-page":"1304792","DOI":"10.3389\/fimmu.2024.1304792","volume":"15","author":"KA Williamson","year":"2024","unstructured":"Williamson KA, Samec MJ, Patel JA et al. Clinical phenotype, NOD2 genotypes, and treatment observations in yao syndrome: a retrospective case series. Frontiers in Immunology. 2024;15:1304792.","journal-title":"Frontiers in Immunology."},{"key":"9240_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14339","volume":"34","author":"WL Hasler","year":"2022","unstructured":"Hasler WL, Grabauskas G, Singh P, Owyang C. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. Neurogastroenterology & Motility. 2022;34:e14339.","journal-title":"Neurogastroenterology & Motility."},{"key":"9240_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cgh.2024.09.007","volume":"23","author":"J Damianos","year":"2024","unstructured":"Damianos J, Abdelnaem N, Camilleri M. Gut goo: Physiology, diet, and therapy of intestinal mucus and biofilms in gastrointestinal health and disease. Clinical Gastroenterology and Hepatology. 2024;23:205.","journal-title":"Clinical Gastroenterology and Hepatology."},{"key":"9240_CR31","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/nu16203494","volume":"16","author":"A Matar","year":"2024","unstructured":"Matar A, Damianos JA, Jencks KJ, Camilleri M. Intestinal barrier impairment, preservation, and repair: An update. Nutrients. 2024;16:3494.","journal-title":"Nutrients."},{"key":"9240_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jaad.2019.09.020","volume":"88","author":"Q Yao","year":"2023","unstructured":"Yao Q. Effectiveness of canakinumab for the treatment of patients with Yao syndrome. Journal of the American Academy of Dermatology. 2023;88:653\u2013654.","journal-title":"Journal of the American Academy of Dermatology."},{"key":"9240_CR33","doi-asserted-by":"publisher","first-page":"1307394","DOI":"10.3389\/fmed.2024.1307394","volume":"11","author":"I Aggeletopoulou","year":"2024","unstructured":"Aggeletopoulou I, Kalafateli M, Tsounis EP, Triantos C. Exploring the role of IL-1\u03b2 in inflammatory bowel disease pathogenesis. Front Med (Lausanne). 2024;11:1307394.","journal-title":"Front Med (Lausanne)."},{"key":"9240_CR34","first-page":"1","volume":"33","author":"CE Gallenga","year":"2019","unstructured":"Gallenga CE, Pandolfi F, Caraffa A et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents. 2019;33:1\u20136.","journal-title":"J Biol Regul Homeost Agents."},{"key":"9240_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2016.02.018","volume":"778","author":"SC Bischoff","year":"2016","unstructured":"Bischoff SC. Mast cells in gastrointestinal disorders. European Journal of Pharmacology. 2016;778:139\u2013145.","journal-title":"European Journal of Pharmacology."},{"key":"9240_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2036.2011.04684.x","volume":"34","author":"G Bassotti","year":"2011","unstructured":"Bassotti G, Villanacci V, Nascimbeni R et al. Colonic mast cells in controls and slow transit constipation patients. Alimentary Pharmacology & Therapeutics. 2011;34:92\u201399.","journal-title":"Alimentary Pharmacology & Therapeutics."},{"key":"9240_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","volume":"65","author":"MM Wouters","year":"2016","unstructured":"Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155\u2013168.","journal-title":"Gut."},{"key":"9240_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.gastro.2024.03.014","volume":"167","author":"M Khasawneh","year":"2024","unstructured":"Khasawneh M, Black CJ, Ford AC. Efficacy of drugs acting on histamine 1 receptors in irritable bowel syndrome: systematic review and meta-analysis. Gastroenterology. 2024;167:400-401.e403.","journal-title":"Gastroenterology."},{"key":"9240_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00261-015-0605-7","volume":"41","author":"TE-M Kaltenbach","year":"2016","unstructured":"Kaltenbach TE-M, Engler P, Kratzer W et al. Prevalence of benign focal liver lesions: Ultrasound investigation of 45,319 hospital patients. Abdominal Radiology. 2016;41:25\u201332.","journal-title":"Abdominal Radiology."},{"key":"9240_CR40","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s10620-015-4007-z","volume":"61","author":"A O\u2019Toole","year":"2016","unstructured":"O\u2019Toole A, Lucci M, Korzenik J. Inflammatory bowel disease provoked by etanercept: report of 443 possible cases combined from an IBD referral center and the FDA. Digestive Diseases and Sciences. 2016;61:1772\u20131774.","journal-title":"Digestive Diseases and Sciences."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:21:08Z","timestamp":1760595668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9240"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09240-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Damianos receives clinical trial funding and consulting fees from ExeGi Pharma, as well as speakers bureau fees from i-Health. Dr. Davis has research support from Pfizer and has technology licensing agreements with Girihlet and Remission Medical. He has provisional U.S. patent application no. 63\/243,933 entitled, \u201cMethods and Materials for Assessing and Treating Arthritis,\u201d which has been licensed to NLC Ventures. Dr. Loftus is a consultant for AbbVie, Alvotech, Amgen, Arena, Avalo, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly, Fresenius Kabi, Genentech, Gilead, GlaxoSmithKline, Gossamer Bio, Iota Biosciences, Iterative Health, Janssen, Morphic, Ono, Protagonist, Sun, Surrozen, Takeda, and UCB. He has research support from AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene\/Receptos, Janssen, Takeda, Theravance, and UCB. He is a shareowner of Exact Sciences.\u00a0Dr. Murray has received research grants from Nexpep\/ImmusanT, National Institutes of Health, Immunogenix, Takeda Pharmaceutical, Allakos, ProventionBio, Oberkotter Foundation, and 9\u00a0m, Inc.; contract (to institution) from Kanyos Bio (a wholly owned subsidiary of Anokion); and consultancy fees from Johnson and Johnson, Bristol-Myers Squibb, Intrexon Corporation, Dren Bio, Neoleukin, Reistone pharma, Immunic Therapeutics, Senda Biosciences, Brightseed Bio, Chugai Pharma, Alimentiv, Equillium, Ukko, Vial Health Technologies and has received royalties from Torax Medical and Evelo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}